Total Health

 

Total Health is the largest provider of free cancer care resources for people who are treating or living with cancer. Our programs arm cancer care teams with the latest research and strategies to improve patient outcomes.

For more info visit our website at Total Health.


 

2020 ASCO Highlights on Stage 3 EGFR+ NSCLC: Should Osimertinib Be Considered for Patients With EGFR Exon 21 Mutation in Adjuvant Setting?

0 views
September 28, 2020
Comments 0
Login to view comments. Click here to Login